Delhi HC turns down Syngenta plea on molecule registration

August 23, 2009 07:05 pm | Updated 07:05 pm IST - New Delhi

The Delhi High Court has dismissed a petition by multinational chemicals giant Syngenta challenging the government’s decision to allow rival firm Crystal Phosphates to import a key insecticide and sell in India, currently exclusively sold here by the MNC.

A single-member Bench of Justice S Ravindra Bhatt dismissed Syngenta’s petition, observing that the plea filed by the Swiss MNC was “speculative” in nature and the court could not intervene in the government’s policy decision.

“The court is of the opinion that the litigation was speculative as the attempt was clearly to invite the court to make a policy declaration, which could not have been made under any circumstances,” said Justice Bhatt, dismissing the Swiss MNC’s petition.

The Court also imposed a cost of Rs 3.75 lakh and directed it to pay to Crystal within four weeks.

In its petition, the Swiss firm had challenged the decision of a committee of the Ministry of Agriculture to grant the registration of insecticide molecule Emammectin Benzoate (five per cent) SG to Chrystal on a host of issues including an abridgement of its intellectual property rights.

Emammectin Benzoate is used in a number of crops, including sugarcane, cotton and wheat. Currently, only Syngenta is selling this insecticide in India.

A Syngenta spokesperson said the company may move the Supreme Court against this verdict.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.